Overview
Venue and Accommodations
Learning Objectives
Agenda
Faculty
Online Registration Form
Fax Registration Form
      Program Overview  
   

Current Approaches in the Treatment of Colorectal Cancer (Predictive and Prognostic Biomarkers) and Non-colorectal Gastrointestinal Cancers

Program Director
Scott Kopetz, MD, PhD

November 15, 2014
Houston Marriott at the Texas Medical Center
6580 Fannin Street, Houston;  Website

Jointly sponsored by
The A. Webb Roberts Center for CME of Baylor Health Care System, CancerNet and American Health Resource, Inc.

For online registration and more information visit: www.cancernetus.com

Educational Grants
This activity is supported by education grants from:
Genentech; Lilly USA, LLC

Statement of Need/Program Overview This symposium is intended to improve care of patients with colorectal and non-colorectal gastrointestinal cancers by accelerating adoption of new guidelines and evidence-based practice change. The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty

Target Audience
This symposium is intended to improve care of patients with colorectal and non-colorectal gastrointestinal cancers by accelerating adoption of new guidelines and evidence-based practice change. The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty

Learning Objectives

After completing this activity, the participant should be better able to:

  • Outline treatment options for advanced/metastatic breast cancer
  • Describe the current status of chemotherapy for colorectal cancer with BRAF and other mutations
  • Appraise the importance of the emerging role of RAS mutations in patients undergoing resection of colorectal liver metastases
  • Explain the data on utilization of alternate angiogenesis inhibitors in colorectal cancer and the role of all-RAS wild-type mutation status
  • Describe the role of EGFR inhibitors in combination with chemotherapy in patients with KRAS and other mutations
  • Explain the data on utilization of alternate angiogenesis inhibitors in colorectal cancer
  • Explain the multidisciplinary approaches in the management of rectal cancer
  • Describe the radiation therapy options for rectal and non-colorectal gastrointestinal cancers
  • Describe current treatment options for the management of hepatocellular carcinoma
  • Identify advances in the treatment of esophagogastric carcinoma
  • Identify advances in the treatment of pancreatic carcinoma
  • Utilize appropriate supportive cancer care options in the era of targeted therapy

Registration Fee
Registration fee partially covers continental breakfast, lunch and syllabus book

Regular
Registration Fee
11/10/14 to 11/15/14

Physicians $135.00
Registered Nurses $85.00
Nurse Practitioners/Physician Assistants $85.00
Pharmacists $85.00
Fellows $85.00
*Industry $350.00
*Person(s) employed by for-profit organizations such as pharmaceutical and biotech companies, and financial institutions

Payment may be made: Master Card   Visa  Discover  Check

Credit Card Number___________________________ Expiration Date_______________

Name and address________________________________________________________
________________________________________________________________________
________________________________________________________________________
Signature________________________________________________________________
As given on the monthly credit card statement
No refund. Substitution is allowed.

Register online at www.cancernetus.com

Please make checks payable to CancerNet, LLC. Mail checks to CancerNet, 860 Hebron Pkwy, Suite 1104, Lewisville, TX 75057

To reserve your place for the meeting, please complete the registration form and fax it 443-267-0016. For questions if any please call Brian Waggoner at 972-459-5222 or E-mail: brianw@cancernetus.com

Physician Continuing Education

Accreditation Statement
The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation
The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement
This activity provides 6.25 contact hour (0.0625 CEU) of continuing education credit. ACPE Universal Activity Number: 0280-9999-14-081-L01-P Knowledge based Initial Release Date: November 15, 2014

Credit Designation
This activity provides 6.5 contact hours (0.65 CEUs) - Knowledge based credits ACPE Universal Activity Number: 0280-9999-14-066-L01-P.

Nursing Continuing Education
Accreditation Statement

American Health Resources, Inc. is approved by the California Board of Registered Nursing, Provider # CEP 14254 and approved this program for 6.25 contact hours. Please check with licensing board to verify credits can be claimed in your state.

Participant Requirement and Statement of Credit:

  • Participants must fully attend all sessions as well as pass in a completed signature verification form with NAPB e-profile number and birth date (MMDD) information (No partial credit will be given).
  • Participants can earn Continuing Pharmacy Education credits for this program by electronically logging onto the website https://ce.ahrevents.com/ and completing the session evaluation form for sessions attended within 60 days of session date. After completion of the activity evaluation, your continuing pharmacy education credit is automatically reported to CPE Monitor where a certificate of credit can be printed. Please allow up to 48 hours for credit to be available on the CPE Monitor.
  • Participant names will be checked against program attendance sheets for verification of attendance.

 
             


Home    |     Live Events    |     Webcasts    |     About CancerNet    |     Contact Us

Copyright © 2012 Cancernet. All rights reserved.